This allows for a once-weekly dose to maintain a consistent level of the drug in your system, which is why the injectable format is currently the gold standard for clinical weight loss results
ACC/AHA guidelines flag levels above 2.0 mg/L as higher cardiovascular risk
Future research should explore not only who responds to GLP-1 RA pharmacotherapy, but also how to maintain progress once medication ends, especially in vulnerable subgroups
The SURMOUNT-5 trial (Rosenstock et al., Lancet 2025) showed 24.2% mean weight loss at 48 weeks, compared to 15.7% for semaglutide 2.4 mg
The weight loss injection Saxenda has also seen a lot of search interest, recording an average of 90,500 searches per month
Lifestyle Changes for Maximum Results While semaglutide is powerful, combining it with healthy lifestyle changes maximizes results and sets you up for long-term success